Recover Investment Losses: Class Action Initiated Against Baxter International, Inc. (BAX)

Core Points - A class action securities lawsuit has been filed against Baxter International, Inc. for alleged securities fraud affecting shareholders between February 23, 2022, and July 30, 2025 [2][3] - The lawsuit claims that Baxter's Novum LVP product had systemic defects leading to serious patient risks, including underinfusion, overinfusion, and non-delivery of fluids [3] - Allegations include that Baxter was aware of multiple malfunctions and injuries but failed to implement adequate remedial measures, resulting in misleading statements about the product's safety and sales prospects [3] Company Details - Baxter International, Inc. is facing legal challenges due to claims of product defects in its Novum LVP, which could lead to significant financial repercussions for the company [3] - The lawsuit highlights the potential for Baxter to halt new sales of the Novum LVP and remove existing units from service, indicating a serious impact on the company's operations and reputation [3] Legal Representation - Levi & Korsinsky LLP, a recognized securities litigation firm, is representing the shareholders in this case, emphasizing their experience and success in similar lawsuits [5]